NIPSNAP3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
4.17820000000457E-05 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
3.221600E-01 |
Stage1-vs-Stage3 |
2.264500E-02 |
Stage1-vs-Stage4 |
7.538900E-03 |
Stage2-vs-Stage3 |
3.638200E-02 |
Stage2-vs-Stage4 |
2.177800E-02 |
Stage3-vs-Stage4 |
7.226400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
2.62156962804738E-12 |
Normal-vs-Asian |
1.080840E-03 |
Caucasian-vs-AfricanAmerican |
4.556800E-01 |
Caucasian-vs-Asian |
9.247800E-01 |
AfricanAmerican-vs-Asian |
8.425600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.63602464908763E-12 |
Male-vs-Female |
7.234300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.17603754196716E-12 |
Normal-vs-Age(41-60Yrs) |
1.62647673107585E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
6.61079999630942E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.959200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.205400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.874800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.347800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.243200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.936600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.26719999996128E-07 |
Normal-vs-Grade 2 |
1.01130215313106E-11 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
4.284000E-01 |
Grade 1-vs-Grade 3 |
3.554600E-01 |
Grade 1-vs-Grade 4 |
7.018700E-03 |
Grade 2-vs-Grade 3 |
4.162500E-03 |
Grade 2-vs-Grade 4 |
3.75959999998621E-06 |
Grade 3-vs-Grade 4 |
2.562900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.93980054241649E-10 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
1.58580999999325E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63846713974181E-12 |
Normal-vs-N1 |
2.04440000040051E-07 |
N0-vs-N1 |
2.468400E-01 |
|
|